Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

In Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Give your PAH patients a second wind

New Ventavis 20 mcg/mL
Shorter treatment times. Higher concentration.

The only inhaled PAH therapy to demonstrate a spectrum of PAH efficacy.

Smart technology from the I-neb AAD by Philips Respironics

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud’s phenomenon and ischaemia. It was developed by the pharmaceutical company Schering AG and is marketed by Bayer Schering Pharma AG in Europe and Actelion Pharmaceuticals in the USA.

More on Wikipedia

Brand name: Ventavis
Generic name/category: Iloprost, Prostaglandins, Alkynes
Company: Actelion
Country/Market: USA, North America
Indication(s)/use: Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Target: Healthcare Professionals (HCP)
Tagline: A spectrum of inhaled PAH efficacy
Medium: Print ad
Size/duration: three-page spread
Publication/Aired: Chest – September 2009

To see all of this brand’s ads on AdPharm, click here

The print ads can be viewed in full size on AdPharm

Not enough lashes?
Grow them with Latisse!

Brand name: Latisse
Generic name/category: Bimatoprost, Prostaglandins, Cosmetic chemicals
Company: Allergan
Country/Market: USA, North America
Indication(s)/use: Eyelash hypotrichosis
Target: Consumers (DTC)
Tagline: Longer, fuller, darker
Medium: Print ads and TV commercial
Size/duration double-page spread, single-page and 60 seconds commercial
Publication/Aired: 2009

To see all of this brand’s ads on AdPharm, click here